Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Migraine Medication Developers Feeling No Pain
Minyanville
Thursday, September 9, 2010 - 5:50pm
tags:
migraines, MAP Pharmaceuticals, Novartis, Valeant Pharmaceuticals, Biovail, Allergan, Botox, Migranal, Levadex, Zogenix
FDA Asks For “Restraint” On Drug Safety Worries
Forbes
Thursday, September 9, 2010 - 5:47pm
tags:
FDA, drug safety, Vioxx, Avandia, Merck, Pfizer, GSK, Spiriva, Boehringer Ingelheim
Amid Western cuts, Roche staffs up in China
Fierce Pharma
Thursday, September 9, 2010 - 1:46pm
tags:
China, Roche, layoffs
After Fine, Botox Awaits Approval for Migraine
NY Times, NY
Thursday, September 9, 2010 - 1:44pm
tags:
migraines, FDA, Botox, Allergan
Acceleron inks $498M pact with Shire for lead muscle drug
Fierce Biotech
Thursday, September 9, 2010 - 12:30pm
tags:
Shire, Acceleron
Genzyme Investors Push for Sanofi Bid of $75 a Share
Bloomberg Businessweek
Thursday, September 9, 2010 - 12:28pm
tags:
Genzyme, investors, M&A, Sanofi
J&J giving $200 million for health of women, kids
Yahoo/AP
Thursday, September 9, 2010 - 12:26pm
tags:
JNJ, donations
EU agency poses new questions on Glaxo's Avandia
Reuters
Thursday, September 9, 2010 - 11:25am
tags:
Europe, GSK, Avandia, diabetes, EMA
Health-Overhaul Law Will Have ‘Moderate’ Spending Effect
WSJ Online
Thursday, September 9, 2010 - 11:22am
tags:
healthcare reform, Medicare, Eli Lilly, GSK
Santarus jumps on drug launch news
Marketwatch
Thursday, September 9, 2010 - 11:21am
tags:
Santarus, diabetes, Cycloset
Today's Buy Opportunity: Teva Pharmaceutical
Motley Fool
Thursday, September 9, 2010 - 11:19am
tags:
Teva Pharmaceuticals
J&J to Cease Drug Sale in Switzerland
TheStreet.com
Thursday, September 9, 2010 - 11:18am
tags:
JNJ, Switzerland, Zevtera
Emergent and Trubion say US clears acquisition
Yahoo/AP
Thursday, September 9, 2010 - 7:16am
tags:
Emergent BioSolutions, Trubion, M&A
Questcor: FDA Delays Drug Approval
TheStreet.com
Thursday, September 9, 2010 - 7:15am
tags:
Questcor Pharmaceuticals, FDA, Acthare, infantile spasms
Lilly Invests $150 Million With Venture Firms Seeking New Drug Candidates
Bloomberg
Thursday, September 9, 2010 - 6:34am
tags:
Eli Lilly, venture capital, drug development
MAP Pharmaceuticals reports positive study results for potential migraine treatment Levadex
Yahoo/AP
Thursday, September 9, 2010 - 6:32am
tags:
MAP Pharmaceuticals, Levadex, migraines
Endo Pharmaceuticals Laying Off Sales Teams
Pharmalot
Wednesday, September 8, 2010 - 6:32pm
tags:
Endo, layoffs, inVentiv, contract sales
BMS: Is This Drugmaker a Lavish Spender or a Bargain Hunter?
Motley Fool
Wednesday, September 8, 2010 - 2:57pm
tags:
Bristol-Myers Squibb, ZymoGenetics, M&A
Zogenix files for $90M IPO
Fierce Biotech
Wednesday, September 8, 2010 - 1:55pm
tags:
Zogenix, IPOs, migraines
Boo! Wyeth And Its Ghostwriting Practices
Pharmalot
Wednesday, September 8, 2010 - 1:54pm
tags:
Wyeth, Ghostwriting, HRT, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.